top of page
/ Programs
SCM06 Formula


A clinical trial evaluating the safety and efficacy of SCM06, a synbiotic formula, in ASD children with anxiety and sensory sensitivity.
Assess safety and tolerability
Evaluate effects on anxiety and sensory hyperresponsiveness
Analyze gut microbiome and metabolome changes
12-week intervention
Symptom tracking at baseline, Week 6, and Week 12
Synbiotic formula SCM06 shows symptom relief in children with ASD
Anxiety symptoms improved within the first 6 weeks and stayed stable by week 12.
Sensory sensitivity showed improvement by week 12.
Changes in Anxiety and Sensory Hypersensitivity Symptoms over 12-week Course of SCM06

bottom of page